MDWD
MDWD
NASDAQ · Pharmaceuticals

Mediwound Ltd

$14.25
+0.92 (+6.90%)
As of Nov 7, 2:18 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +173.3% upside
Low Target $25.16
Average Target $38.94
High Target $46.24
Current Price $14.25
Current
$14.25
Target
$38.94
$25.16 $38.94 avg $46.24
Scenario Analysis
Bear Case
$25.16
76.6%
Low target
Base Case
$38.94
+173.3%
Avg target
Bull Case
$46.24
+224.5%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$19.70
-27.7% from high
52-Week Low
$11.80
+20.8% from low
Target vs 52W High
$38.94
+97.7% vs high
Next Earnings Report
Nov 12, 2026 · Before Market Open
4d
until earnings
EPS Est: $-0.72
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%